These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 36013483

  • 1. Recurrence Outcome in Hepatocellular Carcinoma within Milan Criteria Undergoing Microwave Ablation with or without Transarterial Chemoembolization.
    Chen G, Chen H, Huang X, Cheng S, Zheng S, Wu Y, Zheng T, Chen X, Guo X, Zhang Z, Xie X, Zhang B.
    Medicina (Kaunas); 2022 Jul 29; 58(8):. PubMed ID: 36013483
    [Abstract] [Full Text] [Related]

  • 2. Transarterial chemoembolization combined with microwave ablation versus microwave ablation only for Barcelona clinic liver cancer Stage B hepatocellular carcinoma: A propensity score matching study.
    Li X, Chen B, An C, Cheng Z, Han Z, Liu F, Yu J, Liang P.
    J Cancer Res Ther; 2020 Sep 29; 16(5):1027-1037. PubMed ID: 33004744
    [Abstract] [Full Text] [Related]

  • 3. Microwave ablation after downstaging of hepatocellular carcinoma: outcome was similar to tumor within Milan criteria.
    Shi F, Lian S, Mai Q, Mo Z, Zhuang W, Cui W, Shen L, Chen M, Wu P, Chen X.
    Eur Radiol; 2020 May 29; 30(5):2454-2462. PubMed ID: 32002636
    [Abstract] [Full Text] [Related]

  • 4. Transarterial chemoembolization combined with microwave ablation and apatinib in patients with Barcelona clinic liver cancer Stage C hepatocellular carcinoma: A propensity score matching analysis.
    Shuanggang C, Shen L, Qiu Z, Qi H, Cao F, Xie L, Fan W.
    J Cancer Res Ther; 2020 May 29; 16(2):250-257. PubMed ID: 32474509
    [Abstract] [Full Text] [Related]

  • 5. Combination transarterial chemoembolization and microwave ablation improves local tumor control for 3- to 5-cm hepatocellular carcinoma when compared with transarterial chemoembolization alone.
    Smolock AR, Cristescu MM, Hinshaw A, Woo KM, Wells SA, Ziemlewicz TJ, Lubner MG, Dalvie PS, Louis Hinshaw J, Brace CL, Ozkan OS, Lee FT, Laeseke P.
    Abdom Radiol (NY); 2018 Sep 29; 43(9):2497-2504. PubMed ID: 29450606
    [Abstract] [Full Text] [Related]

  • 6. Comparison of the Efficacy and Prognostic Factors of Transarterial Chemoembolization Plus Microwave Ablation versus Transarterial Chemoembolization Alone in Patients with a Large Solitary or Multinodular Hepatocellular Carcinomas.
    Zheng L, Li HL, Guo CY, Luo SX.
    Korean J Radiol; 2018 Sep 29; 19(2):237-246. PubMed ID: 29520181
    [Abstract] [Full Text] [Related]

  • 7. Transarterial Chemoembolization Monotherapy Versus Combined Transarterial Chemoembolization-Microwave Ablation Therapy for Hepatocellular Carcinoma Tumors ≤5 cm: A Propensity Analysis at a Single Center.
    Chen QF, Jia ZY, Yang ZQ, Fan WL, Shi HB.
    Cardiovasc Intervent Radiol; 2017 Nov 29; 40(11):1748-1755. PubMed ID: 28681222
    [Abstract] [Full Text] [Related]

  • 8. Prognostic factors for survival after transarterial chemoembolization combined with microwave ablation for hepatocellular carcinoma.
    Ni JY, Sun HL, Chen YT, Luo JH, Chen D, Jiang XY, Xu LF.
    World J Gastroenterol; 2014 Dec 14; 20(46):17483-90. PubMed ID: 25516662
    [Abstract] [Full Text] [Related]

  • 9. Transarterial Chemoembolization Combined with Lenvatinib Plus Sequential Microwave Ablation for Large Hepatocellular Carcinoma Beyond Up-to-Seven Criteria: A Retrospective Cohort Study.
    Tang L, Hou Y, Huang Z, Huang J.
    Acad Radiol; 2024 Jul 14; 31(7):2795-2806. PubMed ID: 38290885
    [Abstract] [Full Text] [Related]

  • 10. Microwave ablation and synchronous transarterial chemoembolization combined with PD-1 inhibitor in patients with hepatocellular carcinoma following tyrosine kinase inhibitor intolerance.
    Shi Q, Zhou X, Zhang Z, Zhang W, Ma J, Yang M, Yu J, Luo J, Liu L, Yan Z.
    Front Immunol; 2022 Jul 14; 13():1097625. PubMed ID: 36703965
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of microwave ablation versus radiofrequency ablation for hepatocellular carcinoma: a propensity score analysis.
    Suwa K, Seki T, Aoi K, Yamashina M, Murata M, Yamashiki N, Nishio A, Shimatani M, Naganuma M.
    Abdom Radiol (NY); 2021 Aug 14; 46(8):3790-3797. PubMed ID: 33675382
    [Abstract] [Full Text] [Related]

  • 12. Single medium-sized hepatocellular carcinoma treated with sequential conventional transarterial chemoembolization (cTACE) and microwave ablation at 4 weeks versus cTACE alone: a propensity score.
    Zhu ZY, Yuan M, Yang PP, Xie B, Wei JZ, Qin ZQ, Qian Z, Wang ZY, Fan LF, Qian JY, Tan YL.
    World J Surg Oncol; 2022 Jun 10; 20(1):192. PubMed ID: 35689233
    [Abstract] [Full Text] [Related]

  • 13. Benefits of step-by-step debulking microwave ablation for huge unresectable hepatocellular carcinoma patients after transcatheter arterial chemoembolization refractoriness.
    Huang T, Qi H, Shen L, Wu Y, Song Z, Cao F, Liu Y, Xie L, Chen S, Tang T, Li H, Zhang Y, Feng L, Zhang H, Chen J, Fan W.
    Int J Hyperthermia; 2022 Jun 10; 39(1):935-945. PubMed ID: 35853727
    [Abstract] [Full Text] [Related]

  • 14. Microwave ablation versus radiofrequency ablation for subcapsular hepatocellular carcinoma: a propensity score-matched study.
    Zheng H, Liu K, Yang Y, Liu B, Zhao X, Chen Y, Feng Y, Meng M, Tan X, Zhu Q.
    Eur Radiol; 2022 Jul 10; 32(7):4657-4666. PubMed ID: 35092477
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Small single perivascular hepatocellular carcinoma: comparisons of radiofrequency ablation and microwave ablation by using propensity score analysis.
    An C, Li WZ, Huang ZM, Yu XL, Han YZ, Liu FY, Wu SS, Yu J, Liang P, Huang J.
    Eur Radiol; 2021 Jul 10; 31(7):4764-4773. PubMed ID: 33399908
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Microwave ablation for hepatocellular carcinoma associated with Budd-Chiari syndrome after transarterial chemoembolization: an analysis of ten cases.
    Dou JP, Yu J, Han ZY, Liu FY, Cheng ZG, Liang P.
    Abdom Radiol (NY); 2017 Mar 10; 42(3):962-968. PubMed ID: 27688061
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.